Close Menu
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Give Yourself a 7-Day Financial Reset

January 8, 2026

Pieverse and United Stables Introduce AI-Based Agentic Neobank to Web3 Payments

January 8, 2026

Ethereum’s BPO fork: How it will shape ETH’s 2026 prediction

January 8, 2026
Facebook X (Twitter) Instagram
  • Contact Us
  • Privacy Policy
  • Terms Of Service
Thursday, January 8
Doorpickers
Facebook X (Twitter) Instagram
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking
Doorpickers
Home»Stock Market»Purdue Pharma secures litigation ceasefire after US Supreme Court ruling By Reuters
Stock Market

Purdue Pharma secures litigation ceasefire after US Supreme Court ruling By Reuters

July 11, 2024No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

By Dietrich Knauth

New York (Reuters) – Purdue Pharma has been granted a 60-day freeze on lawsuits against its owners, the Sackler family, by a U.S. court. This decision comes after a landmark Supreme Court ruling that overturned its bankruptcy settlement.

U.S. Bankruptcy Judge Sean Lane approved the injunction at a court hearing in White Plains, New York, stating that the litigation ceasefire will allow Purdue to renegotiate a comprehensive settlement regarding lawsuits alleging that its painkiller OxyContin contributed to the opioid addiction crisis in the United States.

The Supreme Court’s ruling on June 27 determined that Purdue Pharma’s bankruptcy settlement cannot protect the Sacklers, who did not file for bankruptcy themselves, from their involvement in the nation’s opioid epidemic.

This ruling has forced Purdue to revisit its bankruptcy plans after nearly five years and puts at risk the billions of dollars in funding that the company and the Sacklers had committed to addressing the crisis.

Lawsuits filed against Purdue and the Sackler family by various state and local governments, as well as individual plaintiffs, have accused them of contributing to the opioid crisis through deceptive marketing of OxyContin. The company had previously pleaded guilty to misbranding and fraud charges related to its marketing of the drug.

Purdue’s bankruptcy protection has halted the opioid-related lawsuits against the company since 2019, and this shield has now been extended to the Sacklers as well.

Marshall Huebner, Purdue’s attorney, announced plans for expedited mediation involving the Sacklers, government entities, and other stakeholders. He emphasized the importance of the 60-day negotiation period in reaching a new settlement to address opioid overdoses and addiction.

“Every day of delay comes at a tragic cost,” stated Huebner.

Despite the hope for a settlement expressed by several parties, there is a consensus that mediation should adhere to the proposed 60-day schedule.

During the hearing, Judge Lane appointed two mediators, including retired bankruptcy judge Shelley Chapman, to facilitate the settlement talks. If mediation fails, Purdue has indicated that a court-appointed committee representing creditors should be permitted to sue the Sacklers over allegations of financial misconduct.

The Sacklers have denied any wrongdoing and oppose the proposed litigation by creditors. They have expressed willingness to continue settlement negotiations but remain prepared to defend against litigation if talks break down.

© Reuters. FILE PHOTO: The U.S. Supreme Court building is seen in Washington, U.S., May 20, 2024. REUTERS/Evelyn Hockstein/File Photo

“No one is guaranteed a recovery in this court or any other court,” stated Gerard Uzzi, representing the Sackler family members.

Purdue’s previous bankruptcy settlement had widespread support but also faced criticism from individuals like Carrie McGaha, who highlighted the challenges faced by those affected by opioid addiction throughout the bankruptcy proceedings.

ceasefire Court litigation Pharma Purdue Reuters ruling secures Supreme
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Judge Valderrama’s ‘roadmap’ for successful antitrust litigation in affordable housing crisis

January 5, 2026

Coalition challenges CFPB funding cuts in court

December 17, 2025

XRP Secures $1B AUM Milestone, Sets ETF Speed Record In US

December 9, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Trump Signs Executive Order to Create U.S. Sovereign Wealth Fund

February 3, 20253 Views

SEI crypto: Market confidence grows as 3 key areas surge

November 25, 20240 Views

Dave Portnoy Buys Bitcoin, Ethereum, and XRP Amid Signs of Potential Crypto Rebound

November 18, 20251 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest
Personal Finance

Give Yourself a 7-Day Financial Reset

January 8, 20260
Crypto

Pieverse and United Stables Introduce AI-Based Agentic Neobank to Web3 Payments

January 8, 20260
Crypto

Ethereum’s BPO fork: How it will shape ETH’s 2026 prediction

January 8, 20260
Facebook X (Twitter) Instagram Pinterest
  • Contact Us
  • Privacy Policy
  • Terms Of Service
© 2026 doorpickers.com - All rights reserved

Type above and press Enter to search. Press Esc to cancel.